Works matching IS 14642662 AND DT 2012 AND VI 13 AND IP 7
Results: 10
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE Effect of gender and race on the week 48 findings in treatment-naïve,...
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 406, doi. 10.1111/j.1468-1293.2012.00991.x
- By:
- Publication type:
- Article
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 387, doi. 10.1111/j.1468-1293.2011.00984.x
- By:
- Publication type:
- Article
No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 448, doi. 10.1111/j.1468-1293.2012.00995.x
- By:
- Publication type:
- Article
The Recent Infection Testing Algorithm ( RITA) in clinical practice: a survey of HIV clinicians in England and Northern Ireland.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 444, doi. 10.1111/j.1468-1293.2012.00990.x
- By:
- Publication type:
- Article
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 427, doi. 10.1111/j.1468-1293.2012.00994.x
- By:
- Publication type:
- Article
An analysis of patients' understanding of 'routine' preoperative blood tests and HIV screening. Is no news really good news?
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 439, doi. 10.1111/j.1468-1293.2012.00993.x
- By:
- Publication type:
- Article
Nonoccupational post-exposure prophylaxis source tracing: is it really feasible in Australia?
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 436, doi. 10.1111/j.1468-1293.2011.00986.x
- By:
- Publication type:
- Article
HIV testing in community settings in resource-rich countries: a systematic review of the evidence.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 416, doi. 10.1111/j.1468-1293.2012.00992.x
- By:
- Publication type:
- Article
The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir ( DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/ mL at baseline.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 398, doi. 10.1111/j.1468-1293.2012.00989.x
- By:
- Publication type:
- Article